BeOne Medicines Brand Score: 85/100 - Strong Brand tier

Transforming How The World Fights Cancer

BeOne Medicines (beigene.com) scores 85 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 92nd percentile of 13258 Healthcare brands.

AI Snapshot

BeOne Medicines, headquartered in Basel, Switzerland, is a global oncology company founded in 2010. It focuses on advancing cancer care by developing innovative and transformative medicines for patients worldwide. The company combines a broad oncology pipeline with accelerated, rigorous scientific development to improve treatment outcomes. Its work targets people living with cancer, oncology healthcare providers, researchers, and the broader global cancer care community, positioning itself as a leader in expanding access to life-changing cancer treatments.

Key facts about BeOne Medicines
Brand NameBeOne Medicines
Domainbeigene.com
IndustryHealthcare
Founded2010
HeadquartersBasel, Switzerland
Main CompetitorsRoche (82/100), Bristol Myers Squibb (89/100), Merck & Co. (81/100), AstraZeneca (82/100), Novartis (71/100), Pfizer (89/100), AbbVie (84/100), Johnson & Johnson (Janssen Oncology) (87/100)

Evidence

Moz Domain Authority 43/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.

Ranked #617,033 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.

BeOne Medicines has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.

The homepage meta description reads "BeOne Medicines is a global oncology company advancing cancer care through innovative treatments and transformative therapies, improving outcomes for patients worldwide." (Meta description: 21 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.

Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.

AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.

Detected tech stack: Cloudflare, WordPress, Ghost.

Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.

0 Reddit mentions - community discussion signals real-world reputation to AI models.

Does AI know BeOne Medicines?

Live results from asking a general-purpose AI assistant about the brand, checked October 2026.

When asked "What is BeOne Medicines?", Claude could identify the brand as of October 2026. BeOne Medicines is the new name for BeiGene, a global biotechnology company focused on discovering and developing oncology drugs, including its flagship BTK inhibitor Brukinsa used to treat certain blood cancers. Best known for Developing Brukinsa, a leading BTK inhibitor for blood cancers like mantle cell lymphoma and CLL.

When asked "Best brands similar to BeOne Medicines?", Claude would recommend BeOne Medicines as of October 2026. It's a major player in oncology biotech with a commercially successful cancer drug and global research presence, so it's relevant when discussing top cancer-focused biopharma companies.

People Also Ask About BeOne Medicines

Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.

Who are BeOne Medicines's main competitors?

BeOne Medicines's main competitors in Healthcare: Roche (82/100), Bristol Myers Squibb (89/100), Merck & Co. (81/100), AstraZeneca (82/100), Novartis (71/100).

Sources: Brand Analyzer scan

When was BeOne Medicines founded?

BeOne Medicines was founded in 2010. BeOne Medicines operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.

Sources: Wikidata

Does ChatGPT recommend BeOne Medicines?

BeOne Medicines scores 57/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.

Sources: BeOne Medicines official site

What is BeOne Medicines?

BeOne Medicines is a global oncology company headquartered in Basel, Switzerland, founded in 2010. It develops innovative and transformative medicines aimed at improving outcomes for people with cancer worldwide.

Sources: BeOne Medicines official site

What does BeOne Medicines do?

BeOne Medicines researches, develops, and advances cancer treatments. It operates a broad oncology pipeline and applies accelerated, rigorous scientific development processes to bring new cancer therapies to patients globally.

Sources: BeOne Medicines official site

How can BeOne Medicines improve its AI discoverability?

BeOne Medicines can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.

Sources: BeOne Medicines official site

What is BeOne Medicines known for?

BeOne Medicines is known for its broad and deep oncology pipeline and its focus on accelerated, rigorous scientific development aimed at delivering transformative cancer treatments to patients around the world.

Sources: BeOne Medicines official site

Who uses BeOne Medicines?

BeOne Medicines' treatments and research are used by people living with cancer, as well as oncology healthcare providers, researchers, and others within the global cancer care community.

Sources: BeOne Medicines official site

Recommendations

AI visibility

BeOne Medicines scores 64/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.

BeOne Medicines has a moderate AI-visibility profile at 64/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (71/100) and its weakest is recommendation likelihood (57/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #617,033 (Tranco). In a live check, Claude could already identify BeOne Medicines from memory (October 2026) - a sign these signals are paying off.

Visibility - 64/100

Trust - 71/100

Recommendation likelihood - 57/100

Score breakdown - 7 dimensions

The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.

Peer brands

Ranked closest to BeOne Medicines: Befrienders Worldwide (85/100), Beardo (85/100), BENEO (85/100), British Heart Foundation (BHF) (85/100).

A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).

Category leader: Booksy (96/100).

Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.

Add this brand score badge to your site